PRESS RELEASE WASHINGTON D .C. – The Patient Access to Pharmacists’ Treatment Coalition – a combined group of more than 25 institutions representing patients, pharmacists, pharmacies, and additional stakeholders – announced the release of an expanded mass media initiative promoting the role that pharmacists can play in addressing issues seniors face with inadequate access to healthcare services in medically underserved communities through the entire nation. Patients value and trust the role pharmacists play as associates of their healthcare team.

Clovis Oncology reviews net loss of $15.7 million for second quarter 2012 Clovis Oncology, Inc. today reported financial results for the second one fourth 2012, and offered an update on the improvement of its clinical development programs and anticipated milestones for the rest of the year. Mahaffy, CEO and President of Clovis Oncology. ‘We are seeking to broaden our pipeline through our collaboration with Array BioPharma for the discovery of a novel mutant KIT inhibitor; each of our three current clinical applications continues to advance, and most importantly, we remain on track to announce the outcomes from our pivotal LEAP trial of CO-101 in metastatic pancreatic cancer during the fourth quarter this full year.’ 2012 Financial Results and Outlook Clovis reported a net lack of $15.7 million for the next quarter of 2012, and $34.7 million for the first fifty % of 2012.